Clinical trial / 2007
A comprehensive lifestyle intervention with a soy-supplemented vegan diet increased IGFBP-1 without selectively altering IGF-1 compared to usual care.
Researchers evaluated dietary intakes of total protein and soy isoflavones in relation to the IGF axis in prostate cancer patients participating in the Prostate Cancer Lifestyle Trial, which included a very low-fat vegan diet supplemented with 58 g/day of soy protein versus usual care. After one year, the intervention group reported significantly higher intakes of dietary protein and soy isoflavones than controls (P < 0.001). IGF-1 increased significantly in both groups, while IGFBP-1 rose in the experimental group only (P < 0.01). Increases in vegetable protein over one year were associated with increases in IGFBP-1 among intervention patients (P < 0.05).
- Study type
- Randomized controlled trial
- Who was studied
- Prostate cancer patients
- What was measured
- Serum IGF-1 and IGF binding proteins (IGFBPs)
THE PAPER
Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial.
Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll PR, Ornish D. Nutr Cancer, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.